Markets:

Overview

News

Currencies

International

Treasuries

Artivion, Inc. Common Stock (NY:AORT)

46.03 -0.30 (-0.65%)

Streaming Delayed Price Updated: 1:25 PM EST, Dec 30, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Artivion, Inc. Common Stock

< Previous 1 2 3 4 Next >

1 Safe-and-Steady Stock on Our Watchlist and 2 We Avoid

December 28, 2025

Stability is great, but low-volatility stocks may struggle to deliver market-beating returns over time as they sometimes underperform during bull markets.

Via StockStory

3 Cash-Producing Stocks with Questionable Fundamentals

December 17, 2025

While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak...

Via StockStory

Topics Retirement

Artivion (AORT) Stock Is Up, What You Need To Know

December 17, 2025

Shares of medical device company Artivion (NYSE:AORT) jumped 4.6% in the afternoon session after analyst firm Canaccord Genuity reaffirmed its Buy rating and $51.00 price target, pointing to the...

Via StockStory

Topics Artificial Intelligence Economy

3 Russell 2000 Stocks That Concern Us

December 07, 2025

The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher...

Via StockStory

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q3 Teardown: Artivion (NYSE:AORT) Vs The Rest

November 25, 2025

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at medical devices & supplies - cardiology,...

Via StockStory

Oscar Health and Artivion Shares Are Soaring, What You Need To Know

November 21, 2025

A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated...

Via StockStory

Topics Artificial Intelligence Economy Initial Public Offering

5 Must-Read Analyst Questions From Artivion’s Q3 Earnings Call

November 13, 2025

Artivion delivered a Q3 marked by strong revenue growth and a positive market response, as ongoing adoption of its stent grafts and On-X heart valves fueled performance. Management highlighted...

Via StockStory

Topics Earnings

3 Small-Cap Stocks We Approach with Caution

November 12, 2025

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside...

Via StockStory

Gilead Sciences, Moderna, Artivion, Tenet Healthcare, and Charles River Laboratories Stocks Trade Up, What You Need To Know

November 11, 2025

A number of stocks jumped in the afternoon session after the market experienced a sharp sector rotation, as investors fled growth-oriented technology stocks and piled into value-oriented names amid...

Via StockStory

Topics Artificial Intelligence Stocks

November 10, 2025

When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other...

Via StockStory

AORT Q3 Deep Dive: AMDS and On-X Outperform, Pipeline and Reimbursement Bolster Outlook

November 07, 2025

Medical device company Artivion (NYSE:AORT) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 18.4% year on year to $113.4 million. The company’s full-year revenue...

Via StockStory

Artivion Stock: A Deep Dive Into Analyst Perspectives (6 Ratings) ↗

November 07, 2025

Via Benzinga

Artivion Inc (NYSE:AORT) Reports Q3 2025 Revenue Beat and Steady Earnings ↗

November 06, 2025

Artivion (AORT) Q3 2025 revenue beat expectations with 18.4% YoY growth, while EPS aligned with estimates. The medical device firm shows strong momentum.

Via Chartmill

Artivion’s (NYSE:AORT) Q3 Sales Top Estimates

November 06, 2025

Medical device company Artivion (NYSE:AORT) beat Wall Street’s revenue expectations in Q3 CY2025, with sales up 18.4% year on year to $113.4 million. The company’s full-year revenue guidance of $442...

Via StockStory

Artivion (AORT) Reports Q3: Everything You Need To Know Ahead Of Earnings

November 04, 2025

Medical device company Artivion (NYSE:AORT) will be reporting earnings this Thursday after market hours. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence

3 Healthcare Stocks We Find Risky

October 24, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But speed bumps such as inventory destockings have persisted in the wake of...

Via StockStory

Topics Stocks

Firing on All Cylinders: Artivion (NYSE:AORT) Q2 Earnings Lead the Way

October 15, 2025

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the medical devices & supplies - cardiology, neurology, vascular stocks, including Artivion (NYSE:AORT) and its peers.

Via StockStory

3 Reasons to Sell AORT and 1 Stock to Buy Instead

October 15, 2025

What a fantastic six months it’s been for Artivion. Shares of the company have skyrocketed 78.2%, hitting $41.02. This was partly thanks to its solid quarterly results, and the performance may have...

Via StockStory

Topics Supply Chain

1 High-Flying Stock on Our Buy List and 2 We Find Risky

October 13, 2025

Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The flip side though is that these lofty expectations make them particularly...

Via StockStory

Beyond The Numbers: 7 Analysts Discuss Artivion Stock ↗

September 29, 2025

Across the recent three months, 7 analysts have shared their insights on Artivion (NYSE: AORT), expressing a variety of opinions spanning from bullish to bearish.

Via Benzinga

3 Russell 2000 Stocks with Warning Signs

September 29, 2025

The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size also means these businesses often lack the...

Via StockStory

Select Medical, Guardant Health, Artivion, PacBio, and Intuitive Surgical Shares Are Falling, What You Need To Know

September 10, 2025

A number of stocks fell in the afternoon session after markets pulled back, reversing early gains, as investor sentiment remained cautious despite a softer-than-expected inflation reading.

Via StockStory

Topics Economy Stocks

3 Stocks Under $50 We’re Skeptical Of

September 08, 2025

The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to...

Via StockStory

Topics Supply Chain

1 Safe-and-Steady Stock to Consider Right Now and 2 We Ignore

August 31, 2025

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

Via StockStory

PNC Financial Services Group, Truist Financial, U.S. Bancorp, Sweetgreen, and Artivion Shares Skyrocket, What You Need To Know

August 22, 2025

A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested...

Via StockStory

Topics Economy World Trade

3 Hyped Up Stocks with Questionable Fundamentals

August 19, 2025

Exciting developments are taking place for the stocks in this article. They’ve all surged ahead of the broader market over the last month as catalysts such as new products and positive media coverage...

Via StockStory

Topics Supply Chain

1 High-Flying Stock with Exciting Potential and 2 We Find Risky

August 15, 2025

Via StockStory

1 Safe-and-Steady Stock to Target This Week and 2 We Find Risky

August 12, 2025

Low-volatility stocks may offer stability, but that often comes at the cost of slower growth and the upside potential of more dynamic companies.

Via StockStory

AORT Q2 Deep Dive: Product Momentum and Pipeline Advances Drive Upgraded Guidance

August 11, 2025

Medical device company Artivion (NYSE:AORT) beat Wall Street’s revenue expectations in Q2 CY2025, with sales up 15.3% year on year to $113 million. The company’s full-year revenue guidance of $439...

Via StockStory

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.